COPD drug indacaterol cleared for use in NHS Scotland

COPD therapy indacaterol has been accepted for use in NHS Scotland, the Scottish Medicines Consortium (SMC) has announced.

Indacaterol (Onbrez Breez-haler) has been accepted for use as maintenance bronchodilator treatment of airflow obstruction in adults with COPD, the SMC said.

The consortium also accepted dutasteride plus tamsulosin (Combodart) for treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH) and for cutting the risk of acute urinary retention and surgery in patients with moderate to severe symptoms of BPH.

The SMC did not accept betamethasone valerate medicated plaster (Betesil) for the treatment of inflammatory skin disorders which do not respond less potent corticosteroid treatment. The consortium said that Betesil’s manufacturer had not submitted a sufficiently robust economic analysis.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GP time per patient slumps to lowest level in half a decade

GP time per patient slumps to lowest level in half a decade

GP time available per patient has dropped by six and a half minutes since 2015 -...

An uncompromising defender of the NHS: colleagues remember Dr Ron Singer

An uncompromising defender of the NHS: colleagues remember Dr Ron Singer

Colleagues and friends have paid tribute after the death of East London GP Dr Ron...

COVID-19 death rate highest among BAME groups, delayed PHE review confirms

COVID-19 death rate highest among BAME groups, delayed PHE review confirms

Death rates from COVID-19 are highest among patients from BAME groups, according...

GPs face hundreds of complaints over shielding and PPE during pandemic

GPs face hundreds of complaints over shielding and PPE during pandemic

GP practices have faced hundreds of complaints over issues including shielding and...

More than 3,600 GP partners lost in four years as decline accelerates

More than 3,600 GP partners lost in four years as decline accelerates

The number of full-time equivalent (FTE) GP partners in England fell by 3,636 between...

COVID-19 pandemic leaves 2.4m patients stuck in cancer care backlog

COVID-19 pandemic leaves 2.4m patients stuck in cancer care backlog

Around 2.4m patients are waiting longer for cancer tests or treatment because of...